Resurrect Bio Raises £1.61M in Funding

Resurrect Bio

Resurrect Bio, a London, UK-based biotechnology startup focused on the agriculture industry, raised £1.61M in funding.

The round was led by SynBioVen, and also included UKI2S, AgFunder and SHAKE Climate Change Accelerator.

The company intends to use the funds to accelerate product development and strengthen its underlying disease resistance trait-discovery platform.

Led by CEO Dr. Cian Duggan, Resurrect Bio is a spin out company of The Sainsbury Laboratory in Norwich building a platform that leverages gene editing techniques to fix the innate immune system of crops and make crops more resistant to disease. The company uses scientific discoveries, combining a blend of computational biology, Artificial Intelligence (AI), and synthetic biology methods to identify and resurrect native disease resistance genes in crops.

Resurrect Bio works by partnering with key members of the seed industry.